Dynamics of D-serine reflected the recovery course of a patient with rapidly progressive glomerulonephritis.


Journal

CEN case reports
ISSN: 2192-4449
Titre abrégé: CEN Case Rep
Pays: Japan
ID NLM: 101636244

Informations de publication

Date de publication:
11 2019
Historique:
received: 11 06 2019
accepted: 18 07 2019
pubmed: 31 7 2019
medline: 21 5 2020
entrez: 31 7 2019
Statut: ppublish

Résumé

We experienced a case of a 36-year-old female with rapidly progressive glomerulonephritis (RPGN) due to anti-neutrophil cytoplasmic antibody (ANCA)-associated nephritis and systemic lupus erythematosus (SLE) nephritis. Chiral amino acid metabolomics revealed a prominent profile of D-serine in this patient. At the fulminant period of RPGN, the level of plasma D-serine, a potential biomarker in CKD that reflects actual glomerular filtration ratio (GFR), was extremely high. On the other hand, urinary fractional excretion (FE) of D-serine, which was usually much higher than that of L-isoform, was 0% in this patient. These abnormal D-serine profiles normalized in response to the intensive treatment. Normalizations of blood D-serine levels were in parallel with those of blood creatinine levels and potentially reflect the recovery of GFR. FE of D-serine increased transiently before the normalization of D-serine profile, suggesting that kidney promotes urinary excretion of D-serine for the normalization of plasma D-serine level. These unexplored clinical features of D-serine well reflected the clinical course of this patient. Blood D-serine level can also serve as a biomarker in acute kidney injury (AKI) or RPGN, and, in combination with FE of D-serine, may render the clinical practitioners to judge the efficacy of intensive treatments.

Identifiants

pubmed: 31359345
doi: 10.1007/s13730-019-00411-6
pii: 10.1007/s13730-019-00411-6
pmc: PMC6820815
doi:

Substances chimiques

Antibodies, Antineutrophil Cytoplasmic 0
Enzyme Inhibitors 0
Glucocorticoids 0
Immunosuppressive Agents 0
Serine 452VLY9402
Cyclophosphamide 8N3DW7272P
Prednisolone 9PHQ9Y1OLM
Creatinine AYI8EX34EU
Mycophenolic Acid HU9DX48N0T

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

297-300

Références

Biochem J. 1935 Jul;29(7):1620-44
pubmed: 16745832
FEBS Lett. 1992 Jan 13;296(1):33-6
pubmed: 1730289
Sci Rep. 2016 May 18;6:26137
pubmed: 27188851
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4926-31
pubmed: 10781100
Sci Rep. 2019 Mar 25;9(1):5104
pubmed: 30911057

Auteurs

Atsushi Hesaka (A)

KAGAMI Project, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan.
Reverse Translational Research Project, Center for Rare Disease Research, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan.
Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Keiko Yasuda (K)

KAGAMI Project, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan.
Reverse Translational Research Project, Center for Rare Disease Research, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan.

Shinsuke Sakai (S)

Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Hiroaki Yonishi (H)

Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Tomoko Namba-Hamano (T)

Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Atsushi Takahashi (A)

Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Masayuki Mizui (M)

Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Kenji Hamase (K)

Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.

Rakan Matsui (R)

Shiseido Co., Ltd., Tokyo, Japan.

Masashi Mita (M)

Shiseido Co., Ltd., Tokyo, Japan.

Masaru Horio (M)

Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Yoshitaka Isaka (Y)

Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Tomonori Kimura (T)

KAGAMI Project, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan. t-kimura@nibiohn.go.jp.
Reverse Translational Research Project, Center for Rare Disease Research, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan. t-kimura@nibiohn.go.jp.
Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. t-kimura@nibiohn.go.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH